tert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate

Catalog No. :
ACOAEF135
CAS No. :
373604-28-5
Molecular Formula :
C10H18FNO3
Molecular Weight :
219.26

IUPAC Name:tert-butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate

tert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$91.00Login to see priceIn stockInquiry
10g97%$151.00Login to see priceIn stockInquiry
25g97%$301.00Login to see priceIn stockInquiry
100g97%$1084.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate
IUPAC Nametert-butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate
MDL No.MFCD11977352
Molecular FormulaC10H18FNO3
Molecular Weight219.26
SMILESO=C(N1CC(F)C(O)CC1)OC(C)(C)C
InChI KeyXRNLYXKYODGLMI-UHFFFAOYSA-N
Synonymtert-butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate | 373604-28-5 | 1-Boc-3-fluoro-4-hydroxypiperidine | C10H18FNO3 | MFCD11977352 | 1-Piperidinecarboxylic acid, 3-fluoro-4-hydroxy-, 1,1-dimethylethyl ester | 955028-88-3 | 955029-44-4 | cis-tert-butyl3-fluoro-4-hydroxy
CAS No.373604-28-5
PubChem CID42609254

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOAEF135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXMFV741 route compound structure diagram
    --
  2. Then
  3. ACOAEF135 route product structure diagram
    ACOAEF135373604-28-5 In Stock
Inquiry

2. ACOAEF135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOAEF135 route product structure diagram
    ACOAEF135373604-28-5 In Stock
Inquiry

Comments (0)